Aradigm Corp. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
48,131.00
48,240.00
31,462.00
23,597.00
7,095.00
Total Accounts Receivable
92.00
1,058.00
150.00
167.00
200.00
Other Current Assets
1,448.00
1,207.00
3,634.00
1,037.00
389.00
Total Current Assets
49,671.00
50,505.00
35,246.00
24,801.00
7,684.00
Net Property, Plant & Equipment
400.00
502.00
299.00
253.00
289.00
Other Assets
353.00
2,956.00
81.00
-
92.00
Total Assets
50,424.00
53,963.00
35,626.00
25,054.00
8,065.00
Accounts Payable
619.00
2,706.00
1,789.00
711.00
903.00
Other Current Liabilities
6,658.00
4,063.00
5,727.00
5,137.00
4,563.00
Total Current Liabilities
7,277.00
6,769.00
7,516.00
5,848.00
5,466.00
Long-Term Debt
9,035.00
-
-
13,219.00
15,008.00
Provision for Risks & Charges
297.00
-
-
-
-
Other Liabilities
132.00
8,079.00
5,000.00
5,000.00
122.00
Total Liabilities
16,741.00
14,848.00
12,516.00
24,067.00
20,596.00
Common Equity (Total)
33,683.00
39,115.00
23,110.00
987.00
12,531.00
Total Shareholders' Equity
33,683.00
39,115.00
23,110.00
987.00
12,531.00
Total Equity
33,683.00
39,115.00
23,110.00
987.00
12,531.00
Liabilities & Shareholders' Equity
50,424.00
53,963.00
35,626.00
25,054.00
8,065.00

About Aradigm

View Profile
Address
3929 Point Eden Way
Hayward California 94545
United States
Employees -
Website http://www.aradigm.com
Updated 09/14/2018
Aradigm Corp. operates as a pharmaceutical company, which focuses on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases by pulmonologists. Its technologies include diabetes and pain management, AERx essence devices. The company was founded in 1991 and is headquartered in Hayward, CA.